Home > Insider Trading > Filing (0001209191-11-042500)

Filing Details

Accession Number:: 0001209191-11-042500
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-04 13:00:00
Reporting Period:: 2011-08-02

Filing Date:: 2011-08-04
Accepted Time:: 2011-08-04 17:13:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1030575	Francois Jean Formela	C/O Horizon Pharma, Inc. 1033 Skokie Blvd., Suite 355 Northbrook IL 60062		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-02	1,577,819	$0.00	1,577,819	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	179,740	$0.00	1,757,559	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	387,034	$9.00	2,144,593	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	7,086	$9.00	2,151,679	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	11,834	$9.00	2,163,513	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	352,576	$9.00	2,516,089	No	4	P	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	6,456	$9.00	2,522,545	No	4	P	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	10,782	$9.00	2,533,327	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-08-02	1,577,819	$0.00	1,577,819	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2011-08-02	179,740	$0.00	179,740	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	387,034	$9.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	7,086	$9.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	11,834	$9.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,859,851	Indirect	See FN

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
The Reporting Person is a director of Atlas Venture Associates VI, Inc., the general partner of Atlas Venture Associates VI, L.P., the general partner of Atlas Venture Entrepreneurs' Fund VI, L.P. ("AVE") and Atlas Venture Fund VI, L.P. ("Venture") and the managing limited partner of Atlas Fund VI GmbH & Co. KG ("GmbH"). In such capacities he may be deemed to beneficially own these shares. The Reporting Person disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
Includes 46,003 shares held of record by AVE, 27,544 shares held of record by GmbH and 1,504,272 shares held by Venture.
Includes 5,240 shares held of record by AVE, 3,137 shares held of record by GmbH and 171,363 shares held by Venture.
Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
Securities held in the name of Venture.
Securities held in the name of GmbH.
Securities held in the name of AVE.
Includes 9,520 shares held of record by AVE, 5,700 shares held of record by GmbH and 311,304 by Venture.
These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.